Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 09, 2021 at 04:57 am EDT
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 128.441 million compared to CNY 93.348 million a year ago. Operating income was CNY 23.634 million compared to CNY 14.353 million a year ago. Net income was CNY 18.247 million compared to CNY 11.549 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.04 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.